- Home
- NKTR vs MDXG Comparison
NKTR vs MDXG Comparison
Compare NKTR & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- MDXG
- Stock Information
- Founded
- NKTR 1990
- MDXG 2006
- Country
- NKTR United States
- MDXG United States
- Employees
- NKTR N/A
- MDXG N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- NKTR Health Care
- MDXG Health Care
- Exchange
- NKTR Nasdaq
- MDXG Nasdaq
- Market Cap
- NKTR 1.1B
- MDXG 1.0B
- IPO Year
- NKTR 1994
- MDXG N/A
- Fundamental
- Price
- NKTR $54.35
- MDXG $6.76
- Analyst Decision
- NKTR Strong Buy
- MDXG Buy
- Analyst Count
- NKTR 5
- MDXG 1
- Target Price
- NKTR $89.00
- MDXG $12.00
- AVG Volume (30 Days)
- NKTR 684.3K
- MDXG 1.3M
- Earning Date
- NKTR 11-06-2025
- MDXG 10-29-2025
- Dividend Yield
- NKTR N/A
- MDXG N/A
- EPS Growth
- NKTR N/A
- MDXG N/A
- EPS
- NKTR N/A
- MDXG 0.27
- Revenue
- NKTR $62,600,000.00
- MDXG $393,442,000.00
- Revenue This Year
- NKTR N/A
- MDXG $19.01
- Revenue Next Year
- NKTR N/A
- MDXG $2.36
- P/E Ratio
- NKTR N/A
- MDXG $25.10
- Revenue Growth
- NKTR N/A
- MDXG 14.77
- 52 Week Low
- NKTR $6.48
- MDXG $5.79
- 52 Week High
- NKTR $66.92
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- NKTR 44.64
- MDXG 43.31
- Support Level
- NKTR $52.50
- MDXG $6.33
- Resistance Level
- NKTR $61.81
- MDXG $7.51
- Average True Range (ATR)
- NKTR 3.62
- MDXG 0.33
- MACD
- NKTR -0.51
- MDXG -0.12
- Stochastic Oscillator
- NKTR 19.45
- MDXG 26.75
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.